Call Number (LC) Title Results
KJE2655.79 .P37 2024 The regulation of digital technologies in the EU : act-ification, GDPR mimesis, and EU law brutality at play / 1
KJE2655.79 .S39 2019 Licensing and access to content in the European Union : regulation between copyright and competition law / 1
KJE2655.79 .S39 2019eb Licensing and Access to Content in the European Union Regulation between Copyright and Competition Law. 1
KJE2665 .F37 2014 Networks of power in digital copyright law and policy : political salience, expertise and the legislative process / 2
KJE2665.4 .H49 2011eb Die grenzüberschreitende Lizenzierung von Online-Musikrechten in Europa : eine urheber- und wahrnehmungsrechtliche Studie / 1
KJE2690 .K36 2002eb Film copyright in the European Union / 2
KJE2690 .K36 2016eb Film copyright in the European Union / 1
KJE2695 .B48 2007 Protection for databases : the European database directive and its effects in the Netherlands, France and the United Kingdom / 1
KJE2725 Unified patent protection in Europe : a commentary / 1
KJE2725 .D57 1987 Direct protection of innovation / 1
KJE2725 .L45 2007 Software and patents in Europe / 1
KJE2725 .L45 2007eb Software and patents in Europe / 1
KJE2725 .M393 2016i European patent litigation in the shadow of the unified patent court 1
KJE2725 .S25 2011 Trademark protection and freedom of expression : an inquiry into the conflict between trademark rights and freedom of expression under European law / 1
KJE2725 .U55 2018i Unified patent protection in Europe a commentary / 1
KJE2732.A31973 A42 1995 The European Patent Convention : a commentary / 1
KJE2732 .E94 1995 European design protection : commentary to directive and regulation proposals / 1
KJE2751.B55 S53 2016 Bioproperty, biomedicine, and deliberative governance patents as discourse on life / 1
KJE2751.B55 U38 2014eb Bioethics and the Patent Eligibility of Human Embryonic Stem Cells-Related Inventions in Europe / 1
KJE2751.M44 Evergreening patent exclusivity in pharmaceutical products : supplementary protection certificates, orphan drugs, paediatric extensions and ATMPs /
Pharmaceutical patents under the SPC regulation /
2